T2 Gene 838 843  TFPI
T3 Intervention 1327 1345 early-stage cancer
T4 Condition 956 964 diabetes
T5 Protein 1536 1537 P
T6 Condition 58 90 pancreatic ductal adenocarcinoma
T7 Protein 1756 1757 P
T8 Protein 2046 2047 P
T9 Protein 92 96 PDAC
T11 Biomarker 2118 2125 CA 19‐9
T12 Condition 1625 1633 diabetes
T13 Condition 1071 1079 diabetes
T14 Gene 457 467 tenascin C
T15 Protein 2022 2023 P
T17 Protein 576 580 PDAC
T18 Gene 851 863 TNC-FN III-C
T19 Protein 576 577 P
T20 Gene 410 449 plasma tissue factor pathway inhibitor 
T21 Protein 1589 1590 P
T22 Condition 1084 1096 pancreatitis
T23 Biomarker 488 495 CA 19‐9
T24 Biomarker 869 876 CA 19‐9
T25 Gene 2043 2048  TFPI
T26 Biomarker 1195 1202 CA 19‐9
T28 Intervention 1464 1470 cancer
T30 Protein 2167 2171 PDAC
T31 Protein 1179 1180 P
T32 Disease 726 751 acute biliary obstruction
T33 Protein 2247 2251 PDAC
T34 Condition 1638 1650 pancreatitis
T35 Intervention 564 587 early-stage PDAC plasma
T36 Biomarker 1218 1225 CA 19‐9
T37 Cellular_component 351 372 genomics-based plasma
T38 Gene 2049 2061 TNC-FN III-C
T39 Intervention 1744 1760 early-stage PDAC
T40 Intervention 1452 1470 early-stage cancer
T41 Protein 452 453 P
T42 Protein 92 93 P
T43 Biomarker 231 238 CA 19‐9
T44 Protein 841 842 P
T45 Intervention 2313 2319 cancer
T46 Intervention 2002 2020 early-stage cancer
T47 Protein 2167 2168 P
T48 Intervention 564 580 early-stage PDAC
T50 Organism 881 888 patient
T51 Condition 709 721 pancreatitis
T52 Protein 2247 2248 P
T53 Gene 469 481 TNC-FN III-C
T54 Gene 1182 1194 TNC-FN III-C
